Hepatic AhR Activation by TCDD Induces Obesity and Steatosis via Hepatic Plasminogen Activator Inhibitor-1 (PAI-1)
International Journal of Molecular Sciences · 30.08.2025 · 26 (17) · 8452
DOI: 10.3390/ijms26178452 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.08.2025. Verfasst von Seung Jun Oh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea. Hauptthemen laut MEDLINE: Receptors, Aryl Hydrocarbon, Polychlorinated Dibenzodioxins, Obesity, Liver. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korean government (MSIT).
Abstract (Originalsprache)
Exposure to persistent organic pollutants such as 2,3,7,8-tetrachlorodibenzodioxin (TCDD) increases metabolic disorder risk. In this study, we show that a single intraperitoneal injection of TCDD (10 μg/kg) in C57BL/6J mice induced body weight gain, lipid accumulation in the liver and adipose tissue, macrophage infiltration, and elevated hepatic and serum triglyceride levels after 12 weeks. Despite serum aryl hydrocarbon receptor (AhR) ligand levels normalizing by 12 weeks, the persistent effects suggest TCDD sequestration in fat tissue. TCDD inhibited the expression of mitochondrial proteins (COX1, TOM20, TFAM, H2AX) and reduced mitochondrial oxygen consumption. Liver-specific AhR knockout ameliorated TCDD-induced mitochondrial dysfunction, lipid accumulation, and macrophage infiltration. Mechanistically, TCDD-induced hepatic plasminogen activator inhibitor-1 (PAI-1) promoted adipocyte hypertrophy. In the liver, PAI-1 disrupted the interaction between tissue-type plasminogen activator (tPA) and apolipoprotein B (ApoB), thereby enhancing very-low-density lipoprotein (VLDL) assembly. These findings reveal that hepatocyte-derived circulating PAI-1, upregulated via hepatic AhR activation, contributes to adipocyte hypertrophy and hepatosteatosis through the intracellular modulation of the tPA–PAI-1 axis. Thus, hepatic AhR activation drives mitochondrial dysfunction and obesity, even after a single TCDD exposure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea.
- Biomedical Science Institute, Kyung Hee University, Seoul 02447, Republic of Korea.
- Department of Physiology, School of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
- Department of Nutritional Sciences, College of Human Ecology, Cornell University, Ithaca, NY 14853, USA.
- Department of Oriental Internal Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
ORCID-Profile: Suyeol Im, Sora Kang, Byung Cheol Lee, Youngmi Kim Pak
Förderung
- National Research Foundation of Korea
- Korean government (MSIT)
Zitieren
APA
Oh, S. J., Im, S., Kang, S., Lee, A. G., Lee, B. C., & Pak, Y. K. (2025). Hepatic AhR Activation by TCDD Induces Obesity and Steatosis via Hepatic Plasminogen Activator Inhibitor-1 (PAI-1). International Journal of Molecular Sciences, 26(17), 8452. https://doi.org/10.3390/ijms26178452
Vancouver
Oh SJ, Im S, Kang S, Lee AG, Lee BC, Pak YK. Hepatic AhR Activation by TCDD Induces Obesity and Steatosis via Hepatic Plasminogen Activator Inhibitor-1 (PAI-1). International Journal of Molecular Sciences. 2025;26(17):8452. doi:10.3390/ijms26178452
BibTeX
@article{Oh2025,
author = {Oh, Seung Jun and Im, Suyeol and Kang, Sora and Lee, Aden Geonhee and Lee, Byung Cheol and Pak, Youngmi Kim},
title = {Hepatic AhR Activation by TCDD Induces Obesity and Steatosis via Hepatic Plasminogen Activator Inhibitor-1 (PAI-1)},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {17},
pages = {8452},
doi = {10.3390/ijms26178452}
}
EUVIMED